{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"Zealand commits $30m upfront to Generate for AI-led metabolic drug research","author_name":"techandbusiness.org · AI","thumbnail_url":"https://s.yimg.com/lo/mysterio/api/262f8ae06991918cb30c97acccf4e132c60b0422726155e3a016a81ceef68611/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fpharmaceutical_technology_376%2F52dd1eb52d1e7f9e100b55754dc7059a.jpg","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · AI</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/yVDfHUxAa3Oa7wnvjuXnov\" style=\"color:#fff;text-decoration:none;\">Zealand commits $30m upfront to Generate for AI-led metabolic drug research</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Zealand Pharma will pay Generate Biomedicines $30m upfront for two programmes developing protein-based therapies for obesity and other metabolic diseases. The agreement includes $35m in preclinical mi...</p>\n    </blockquote>"}